InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: north40000 post# 283105

Saturday, 06/27/2020 10:52:55 AM

Saturday, June 27, 2020 10:52:55 AM

Post# of 426181
North

When H enters the market sometime after today, particularly after mid-December 2022 with its generic Vascepa, tell us what you think Amarin will do, hypothetically speaking. How do you think that H escapes any charge of direct infringement in acting to bring its generic Vascepa to market?



The result of this appeal does not change the fact Amarin can take actions against any generic launch, this is why settlement is 100% likely.

The window for settlement is wide open. After this appeal is done...window is closed.

If court decides to rule on just briefs window is actively closing on generics “member”.

BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News